Alabama
Alabaster; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Birmingham; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Birmingham; University of Alabama
RNS™ System Pivotal Clinical Investigation
Huntsville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Northport; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Alaska
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Arizona
Phoenix; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Phoenix; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Arkansas
Little Rock; Clinical Trials, Inc
Epilepsy and non-controlled partial seizures
Little Rock; Clinical Trials, Inc.
Refractory Epilepsy and acute repetitive seizures (ARS)
Little Rock; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Little Rock; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Little Rock; Clinical Trials, Inc.
Epilepsy and non-controlled partial seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
California
Costa Mesa; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Fresno; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
La Jolla; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Los Angeles; UCLA Medical Center
Study of Fish Oil for Intractable Partial Seizures
Los Angeles; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Los Angeles; University of Southern California
RNS™ System Pivotal Clinical Investigation
Newport Beach; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Oxnard; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Pasadena; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Riverside; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Sacramento; Sutter Institute for Medical Research (SIMR)
Epilepsy: Refractory Partial Seizures
Sacramento; Sutter Institute for Medical Research (SIMR)
Epilepsy: Acute Repetitive Seizures
San Diego; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
San Francisco; California Pacific Medical Center
RNS™ System Pivotal Clinical Investigation
Santa Monica; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Sylmar; UCLA Medical Center
Trigeminal Nerve Stimulation for Epilepsy
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Colorado
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Connecticut
Fairfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New Haven; Yale University School of Medicine
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Waterbury; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Delaware
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Florida
Gainesville; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Gainesville; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Gainesville; University of Florida
RNS™ System Pivotal Clinical Investigation
Maitland; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Orlando; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Panama City; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Sarasota; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Sarasota; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Sarasota; Lovelace Scientific Resources - Sarasota
Epilepsy
Tallahassee; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
West Palm Beach; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Georgia
Atlanta; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Atlanta; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Atlanta; Neurotrials Research, Inc.
Do you suffer from Seizures?
Augusta; Medical College of Georgia
RNS™ System Pivotal Clinical Investigation
Canton; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Conyers; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Decatur; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Savannah; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Hawaii
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Idaho
Boise; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Illinois
Chicago; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Springfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Indiana
Danville; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Fort Wayne; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Indianapolis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Indianapolis; Indiana University
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Iowa
Ames; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Kansas
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Wichita; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Wichita; Via Christi Comprehensive Epilepsy Center
RNS™ System Pivotal Clinical Investigation
Kentucky
Louisville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Louisiana
New Orleans; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Maine
Scarborough; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Maryland
Baltimore; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Baltimore; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Baltimore; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Baltimore; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Baltimore; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Baltimore; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Baltimore; Johns Hopkins University
RNS™ System Pivotal Clinical Investigation
Bethesda; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Pikesville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Massachusetts
Boston; MGH - Massachusetts General Hospital
Genotype and Phenotype of Brainstem Injury in Autism, Project IV: Gene-environment interactions in a population exposed to a teratogen associated with autism
Boston; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Boston; MGH - Massachusetts General Hospital![[*]](../images/newtiny.gif)
Does Memantine Improve Verbal Memory Task Performance in Subjects with Left Temporal Lobe Epilepsy and Memory Dysfunction? A Randomized, Double-Blind, Placebo-Controlled Trial.
Boston; MGH - Massachusetts General Hospital
Cognitive Effects of Treatment of Interictal Discharges
Boston; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Boston; Massachusetts General Hospital
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Michigan
Detroit; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Detroit; Henry Ford Hospital
RNS™ System Pivotal Clinical Investigation
Grand Rapids; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Minnesota
Golden Valley; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Minneapolis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Mississippi
Hattiesburg; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Missouri
Chesterfield; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Chesterfield; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Chesterfield; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Chesterfield; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
St Louis; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Montana
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Nebraska
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Nevada
Henderson; Lovelace Scientific Resources, Inc.
Lamotrigine Extended-Release in Elderly Patients with Epilepsy
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
New Hampshire
Lebanon; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Lebanon; Dartmouth-Hitchcock Medical Center
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
New Jersey
Edison; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Voorhees; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Warren; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
New Mexico
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
New York
Albany; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Bronx; Biomedical Research Alliance of New York
Refractory Partial Seizures-Adults and Minors
Bronx; Biomedical Research Alliance of New York
Photosensitivity Study - Adults
Buffalo; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Buffalo; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Buffalo; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Cedarhurst; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New Hyde Park; Biomedical Research Alliance of New York
Bipolar Disorder in Epilepsy
New Hyde Park; Biomedical Research Alliance of New York
Refractory Partial Seizures
New York; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New York; Biomedical Research Alliance of New York
Epilepsy consisting of uncontrolled partial-onset seizures - Adults
New York; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
New York; Biomedical Research Alliance of New York
Refractory Partial Seizures
New York; Biomedical Research Alliance of New York
Epilepsy
New York; Columbia University Medical Center
Multicenter Genetic Study of Rolandic Epilepsy
New York; Biomedical Research Alliance of New York
Refractory Partial Seizures
Rochester; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Rochester; University of Rochester
RNS™ System Pivotal Clinical Investigation
Schenectady; Schenectady Neurological Consultants, PC
Lamictal Extended-Release in Elderly Patients with Epilepsy
Syracuse; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
North Carolina
Asheville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Chapel Hill; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Charlotte; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Durham; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Hickory; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Winston-Salem; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
North Dakota
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Ohio
Cleveland; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Cleveland; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Columbus; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Columbus; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Columbus; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Toledo; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Westerville; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Oklahoma
Oklahoma City; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Oklahoma City; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Tulsa; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Oregon
Medford; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Portland; Oregon Health & Sciences University
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Pennsylvania
Bethlehem; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Jenkintown; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Philadelphia; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Philadelphia; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Philadelphia; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Philadelphia; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Tarentum; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Rhode Island
Providence; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
South Carolina
Beaufort; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
South Dakota
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Tennessee
Germantown; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Nashville; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Nashville; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Nashville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Nashville; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Texas
Austin; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Bedford; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Dallas; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Dallas; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Dallas; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Dallas; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
El Paso; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Fort Worth; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Fort Worth; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Houston; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Houston; Baylor College of Medicine
RNS™ System Pivotal Clinical Investigation
San Antonio; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Temple; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Utah
Layton; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Vermont
Burlington; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Virginia
Bluefield; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Charlottesville; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Charlottesville; University of Virginia
Progesterone Therapy for Women with Epilepsy
Charlottesville; UCB Clinical Trial Call Center
Trial to Assess the Safety of a Single Dose of iv Lacosamide Followed by Twice Daily Oral Lacosamide in Patients With Partial-Onset Seizures.
Charlottesville; UCB Clinical Trial Call Center
Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures
Danville; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Richmond; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Richmond; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Richmond; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Washington
Renton; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Seattle; Swedish Medical Center
RNS™ System Pivotal Clinical Investigation
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Washington, DC
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Washington; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Washington; George Washington University
RNS™ System Pivotal Clinical Investigation
West Virginia
Charleston; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Wisconsin
Madison; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Madison; University of Wisconsin School of Medicine and Public Health
RNS™ System Pivotal Clinical Investigation
Milwaukee; UCB Clinical Trial Call Center
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-Onset Seizures
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
Wyoming
Various Cities; Research Site
Lamotrigine Pregnancy Registry examining pregnancy outcomes of women exposed to lamotrigine
International
Brussels, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Gent, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Gent, Belgium; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Gent, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Kortrijk, Belgium; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Leuven, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Leuven, Belgium; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Leuven, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Liege, Belgium; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Toronto, CANADA; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Windsor, ON, Canada; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Litomysl, CZECH REPUBLIC; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Ostrava, Czech Republic; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Ostrava-Trebovice, Czech Republic; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Praha 2, CZECH REPUBLIC; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Praha-4, CZECH REPUBLIC; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Tampere, FINLAND; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Amiens, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Lille, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Paris, France; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Aschaffenburg, GERMANY; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Berlin, GERMANY; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Heidelberg, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Heidelberg, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Kehl, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Kehl, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Kehl-Kork, Germany; UCB Clinical Trial Call Center
Post-Authorization Safety Study to Assess the Safety of Vimpat as Add-on Therapy in Patients With Partial Onset Seizures (PASS)
Kiel, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Kiel, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Mόnchen, Germany; UCB Clinical Trial Call Center
Post-Authorization Safety Study to Assess the Safety of Vimpat as Add-on Therapy in Patients With Partial Onset Seizures (PASS)
Mόnster, Germany; UCB Clinical Trial Call Center
Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Osnabruck, GERMANY; UCB Clinical Trial Call Center
Post-Authorization Safety Study to Assess the Safety of Vimpat as Add-on Therapy in Patients With Partial Onset Seizures (PASS)
Osnabrόck, Germany; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Stuttgart, Germany; UCB Clinical Trial Call Center
Post-Authorization Safety Study to Assess the Safety of Vimpat as Add-on Therapy in Patients With Partial Onset Seizures (PASS)
Stuttgart, Germany; UCB Clinical Trial Call Center
Post-Authorization Safety Study to Assess the Safety of Vimpat as Add-on Therapy in Patients With Partial Onset Seizures (PASS)
Ulm, GERMANY; UCB Clinical Trial Call Center
Post-Authorization Safety Study to Assess the Safety of Vimpat as Add-on Therapy in Patients With Partial Onset Seizures (PASS)
Kecskemet, HUNGARY; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Pisa, ITALY; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Madrid, SPAIN; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Zaragoza, SPAIN; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam (ucb34714) in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Goteborg, SWEDEN; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Lund, SWEDEN; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Stockholm, Sweden; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
Uppsala, SWEDEN; UCB Clinical Trial Call Center
A Double-Blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (= 16 to 75 Years Old) With Partial Onset Seizures
